Mark Lewis: Rectal cancer is perhaps now the GI cancer par excellence for multidisciplinary treatment planning
Mark Lewis shared a post by Krishan Jethwa, GI Radiation Oncologist at Mayo Clinic, on X:
“We literally used this as part of discussion at tumor board today
Rectal cancer is perhaps now the GI cancer par excellence (not forgetting about esophageal or pancreatic, of course) for multidisciplinary treatment planning.
Look forward to refining management further at ASCO24.”
Quoting Krishan Jethwa‘s post:
“ARS AUC for Non-Operative Management for Rectal Cancer Congrats to Chris Anker and the ARS GI Committee for this systematic review on organ preservation and selective local therapy options for patients with rectal cancer.”
Read further.
Source: Mark Lewis/X and Krishan Jethwa/X
Mark A. Lewis is the Director of Gastrointestinal Oncology at Intermountain Healthcare in Utah, the Co-Chair of adolescent & young adult (AYA) oncology in the SWOG cooperative group, and the Vice President of American Multiple Endocrine Neoplasia Support. Dr. Lewis is also a well-known patient advocate and social media influencer.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023